Compounds > atorvastatin

Page last updated: 2024-08-24

atorvastatin and 3-nitrotyrosine

atorvastatin has been researched along with 3-nitrotyrosine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	3 (50.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheung, R; Mutus, B; Tannous, M; Vignini, A	1
Aviles, RJ; Brennan, ML; Fu, X; Gokce, N; Goormastic, M; Hazen, SL; Keaney, JF; Pearce, GL; Penn, MS; Shishehbor, MH; Sprecher, DL; Vita, JA	1
Aviles, RJ; Brennan, ML; Fu, X; Hazen, SL; Penn, MS; Shishehbor, MH; Sprecher, DL	1
Beckman, JA; Chui, D; Creager, MA; Garrett, LA; Hurley, S; Liao, JK; Mitra, D	1
de Oliveira, CV; Funck, VR; Furian, AF; Grigoletto, J; Oliveira, MS; Pereira, LM; Rambo, LM; Ribeiro, LR; Royes, LF	1
Choudhury, S; Gupta, P; Harikumar, SK; Kannan, K; Mishra, SK; Pillai, AH; Sarath, TS; Sarkar, SN; Waghe, P	1

Trials

3 trial(s) available for atorvastatin and 3-nitrotyrosine

Article	Year
Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects. Thrombosis and haemostasis, 1999, Volume: 82, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Platelets; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Enzyme Induction; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Pyrroles; Treatment Outcome; Triglycerides; Tyrosine; Vasodilation	1999
Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation, 2003, Jul-29, Volume: 108, Issue:4 Topics: Antioxidants; Arteriosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation; Lipoproteins; Male; Middle Aged; Oxidation-Reduction; Prospective Studies; Pyrroles; Reactive Oxygen Species; Signal Transduction; Statistics, Nonparametric; Tyrosine	2003
Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circulation research, 2004, Jul-23, Volume: 95, Issue:2 Topics: Adult; Atorvastatin; Brachial Artery; Cholesterol; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Pyrroles; RNA, Messenger; Skin; Smoking; Tyrosine; Ultrasonography; Vasodilation	2004

Other Studies

3 other study(ies) available for atorvastatin and 3-nitrotyrosine

Article	Year
Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA, 2003, Apr-02, Volume: 289, Issue:13 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Prospective Studies; Pyrroles; Risk Factors; Tyrosine	2003
Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex. Pharmacological research, 2013, Volume: 71 Topics: Animals; Atorvastatin; Cerebral Cortex; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide; Oxidation-Reduction; Pyrroles; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Superoxide Dismutase; Tyrosine	2013
Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats. Toxicology and applied pharmacology, 2014, Nov-01, Volume: 280, Issue:3 Topics: Animals; Aorta, Thoracic; Arsenites; Atorvastatin; Catalase; Cholesterol; Glutathione Peroxidase; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Pyrroles; Random Allocation; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sodium Compounds; Superoxide Dismutase; Tyrosine	2014